Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Meropenem, Ampicillin, Aztreonam, and Ciprofloxacin in APD Patients
NCT07113587Phase 3Completed
- Sponsor
- Karl Landsteiner Institute for Nephrology and Haemato-Oncology
- Start
- Apr 2014
- Primary completion
- Jul 2017
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meropenem, ampicillin, aztreonam, ciprofloxacin in peritoneal dialysis-associated peritonitis, sponsored by Karl Landsteiner Institute for Nephrology and Haemato-Oncology. Started Apr 2014; status: completed.
02
Drugs
meropenemampicillinaztreonamciprofloxacin
03
Conditions
peritoneal dialysis-associated peritonitis
Beyond the preview
Go deeper on NCT07113587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113587.